Fact CheckerSign in

NCT07900035Completed

Myocardial Injury After Transurethral Resection

Incidence and Perioperative Risk Factors of Myocardial Injury After Noncardiac Surgery Following Transurethral Resection of Bladder Tumor: A Prospective Observational Study

Source: ClinicalTrials.gov · Last updated 28 Oct 2026

Brief summary (registry, in English)

This prospective observational study aims to determine the incidence of myocardial injury after noncardiac surgery (MINS) in adult patients undergoing elective transurethral resection of the prostate (TURP) or transurethral resection of bladder tumor (TURBT). High-sensitivity cardiac troponin T (hs-cTnT) levels are measured preoperatively, 1 hour after surgery, and 48 hours postoperatively. Demographic, clinical, anesthetic, and intraoperative variables are prospectively recorded to explore perioperative factors associated with the development of MINS. The primary outcome is the incidence of MINS within 48 hours after surgery.

Status (registry)
Completed
Study type
Observational
Enrollment
89 (actual)
First submitted
14 Oct 2026
Start date
May 2025
Primary completion date
Dec 2025
Lead sponsor
Haseki Training and Research Hospital
NCT number
NCT07900035

What you commit to

  • Study type: Observational
  • Participants enrolled: 89
  • From May 2025 to the primary completion date, Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Myocardial infarction within the previous 6 months
  • Cardioversion within the previous 6 months
  • Surgery within the previous month

Other illness

  • Decompensated heart failure
  • End-stage renal disease requiring dialysis
  • Contraindication to spinal anesthesia, including increased intracranial pressure, infection at the puncture site, coagulopathy, severe hypovolemia, or severe aortic and/or mitral stenosis

Other

  • Refusal to participate
  • Recent pulmonary embolism
  • Body mass index \>40 kg/m²

Who the study is looking for

  • Age ≥18 years
  • ASA physical status I-III
  • Scheduled for elective transurethral resection of the prostate (TURP) or transurethral resection of bladder tumor (TURBT)
  • Written informed consent provided

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Haseki Training and Research Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.